David S. Tierney - May 20, 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ David S. Tierney
Stock symbol
CPRX
Transactions as of
May 20, 2022
Transactions value $
$50,600
Form type
4
Date filed
5/24/2022, 04:30 PM
Previous filing
Feb 16, 2022
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $50.6K +20K +6.49% $2.53 328K May 20, 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -20K -6.09% 308K May 20, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -20K -7.34% $0.00 252K May 20, 2022 Common Stock 20K $2.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Tierney has advised the Company that the sale of shares was to pay the exercise cost of the shares and to raise funds for personal reasons and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company.
F2 12,803 shares were sold at a price of $7.03 per share, 5,626 were sold at a price of $7.04 per share, and 1,571 were sold at a price of $7.05 per share.
F3 The option was granted on December 30, 2015 and previously vested in two annual installments.